Patients Understanding of their Tuberculosis (TB) Medications and their Awareness of Lifestyle Modifications for Post TB Living

Download Article

DOI: 10.21522/TIJPH.2013.09.02.Art032

Authors : Ibrahim Ibn Saana, Philip K. Amoo, Daniel N.A. Ankrah, Kissinger Marfoh, Francis A. Akum, Richard Achiak, Idrissu A Yahaya, Farida N Abdulai6

Abstract:

Medicine’s availability, understanding their administration and radiational use are critical in drug therapeutic outcomes. Advancement in science has led to understanding of the etiology of several disease conditions, yet challenges remain due to patients’ non-adherence to prescribed treatment (14). The purpose of this study was to assess patient’s knowledge and understanding of their TB medications and their awareness of lifestyle modifications to adapt for post TB living. The study also assessed common factors affecting TB patients. A descriptive cross-sectional study was carried out. The study population consisted of 250 diagnosed TB patients attending the Clinic who were systematically selected. An Interviewer administered questionnaire with REDCAP was used to collect data, organized using Excel spreadsheet software and analysed using Statistical Package for Social Sciences (SPSS). Logistic regression was used to establish significance. Results: 63.2% (n=158) were males and 36.8% (n=92) were females with a 100% response rate. 62.8% (n=157) have pulmonary TB, 35.2% (n=88) Extra PTB whiles 2.0% (n=5) MDR-TB. 9.2% (n=23) of patients are aware that TB could reduce their sexual function. Only 20.4% (n=51) knew their medications and 2.7% (n=18) aware of lifestyle changes to adapt post treatment for an improved Quality of Life. 86.4% (n=216) out of the 250 patients received immediate care. Logistic regression showed that Odds ratio at 95% confident interval of the potential predictors were insignificant except age and marital status. Since less than 50% knew their medicines and lifestyle changes to adapt pharmacists and prescribers need to improve on patient education and counselling.

References:

[1] Miggiano R, Rizzi M, Ferraris DM. Mycobacterium tuberculosis pathogenesis, infection prevention, and treatment. Pathogens. 2020; 9(5):10–3.

[2] Denholm J. The use of anti-tuberculosis therapy for latent TB infection. Infect Drug Resist [Internet]. 2010 Jul [cited 2021 Feb 28]; 3:63. Available from: /pmc/articles/PMC3108738/.

[3] for Disease Control C, National Center for HIV P, Hepatitis V, Prevention T. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers.

[4] Latent tuberculosis infection Updated and consolidated guidelines for programmatic management.

[5] Sharma P, Goyal RK, Nandave M. A Review: Prevention, Treatment, and Management of Tuberculosis through Combinational Approaches of Different Indian Systems of Medicine. Vol. 70, Drug research. NLM (Medline); 2020. p. 65–70.

[6] Bonsu F, Addo KK, Alebachew Z, Gyapong J, Badu-Peprah A, Gockah R, et al. National population-based tuberculosis prevalence survey in Ghana, 2013. Vol. 24, International Journal of Tuberculosis and Lung Disease. International Union Against Tuberculosis and Lung Disease (The Union); 2020. p. 321–8.

[7] A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015 Aug 27;373(9):808–22.

[8] Yeong C, Byrne AL, Cho JG, Sintchenko V, Crighton T, Marais BJ. Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation. Int J Infect Dis. 2020 Mar 1; 92:175–80.

[9] Enhanced Reader [Internet]. [cited 2021 Feb 28]. Available from: moz-extension://db692e28-b954-40ef-89aa-598b4eda30fe/enhanced-reader.html?openApp&pdf=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F311259%2F9789241550512-eng.pdf.

[10] Ghana Ministry of Health. The National Tuberculosis Health Sector Strategic Plan for Ghana: 2015-2020. Minist Heal. 2015;1–132.

[11] An exploration of the causes of tuberculosis stigma in an urban district in Ghana | Request PDF [Internet]. [cited 2021 Feb 28]. Available from: https://www.researchgate.net/publication/23180777_An_exploration_of_the_causes_of_tuberculosis_stigma_in_an_urban_district_in_Ghana.

[12] Dodor EA. The feelings and experiences of patients with tuberculosis in the Sekondi-Takoradi Metropolitan district: implications for TB control efforts. Ghana Med J [Internet]. 2012 [cited 2021 Feb 28];46(4):211–8. Available from: /pmc/articles/PMC3645176/.

[13] Evenson W. Occupational Exposure to Mycobacterium tuberculosis Legal Issues in Workers’ Compensation.

[14] Adherence to long therapies: Evidence for action. Geneva, Switzerland (WHO,2003).

[15] Alam AY, Qureshi AA, Adil MM, Ali H. Comparative study of knowledge, attitude and practices among antenatal care facilities utilizing and non-utilizing women. J Pak Med Assoc. 2005; 55:53–6.

[16] Nhamoyebonde S, Leslie A. Biological Differences Between the Sexes and Susceptibility to Tuberculosis. 2014 [cited 2021 Feb 28]; Available from: https://academic.oup.com/jid/article/209/suppl_3/S100/2192832.

[17] Self-Study Modules on Tuberculosis, 6-9 Module 6 Managing Tuberculosis Patients and Improving Adherence Module 6-Managing Tuberculosis Patients and Improving Adherence 2.

[18] Chapter 5: Treatment for Latent Tuberculosis Infection Chapter 5 Treatment for Latent Tuberculosis Infection.

[19] Tuberculosis (TB) - Treatment - NHS [Internet]. [cited 2021 Feb 28]. Available from: https://www.nhs.uk/conditions/tuberculosis-tb/treatment/.

[20] Senanayake MGB, Wickramasinghe SI, Samaraweera S, De Silva P, Edirippulige S. Examining the social status, risk factors and lifestyle changes of tuberculosis patients in Sri Lanka during the treatment period: a cross-sectional study. Multidiscip Respir Med [Internet]. 2018 Dec 1 [cited 2021 Feb 28]; 13(1):9. Available from: https://mrmjournal.biomedcentral.com/articles/10.1186/s40248-018-0121-z.

[21] Jadgal KM, Nakhaei-Moghadam T, Alizadeh-Seiouki H, Zareban I, Sharifi-Rad J. Impact of Educational Intervention on Patients Behavior with Smear-positive Pulmonary Tuberculosis: A Study Using the Health Belief Model. Mater Sociomed. 2015 Aug;27(4):229–33.

[22] Nyasulu P, Sikwese S, Chirwa T, Makanjee C, Mmanga M, Babalola J, et al. Knowledge, beliefs, and perceptions of tuberculosis among community members in Ntcheu district, Malawi. J Multidiscip Healthc [Internet]. 2018 Aug 16 [cited 2021 Feb 28]; Volume 11:375–89. Available from: https://www.dovepress.com/knowledge-beliefs-and-perceptions-of-tuberculosis-among-community-memb-peer-reviewed-article-JMDH.

[23] Amenuvegbe GK, Francis A, Fred B. Low tuberculosis case detection: a community and health facility-based study of contributory factors in the Nkwanta South district of Ghana. BMC Res Notes [Internet]. 2016 Dec 29 [cited 2021 Feb 28]; 9(1):330. Available from:

http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-016-2136-x.

[24] Tuberculosis Control Programme | Programmes | Ghana Health Service [Internet]. [cited 2021 Feb 28]. Available from: https://ghanahealthservice.org/programme-cat.php?ghspid=2&ghscid=70.